However, observational studies have presented contrasting findings, with high levels of acid ceramidase being associated with improved prognosis in breast and ovarian cancers (Ruckhaberle et al., 2009; Hanker et al., 2013; Sanger et al., 2015). This evidence concerns the gene ASAH1 and ovarian cancer.